Consistently, this study confirmed that HDAC6 inhibition using CKD-WID also showed an anti-osteoclastic effect through the suppression of calcineurin and NFATc1 activation downstream in the RANK-RANKL pathway. This evidence concerns the gene HDAC6 and chronic kidney disease.